メニュー
このリポジトリの skills
SkillsMP は dromlakhani/MD2SKILL から 858 件の skill を収集しています。skill を開くとソースと詳細を確認できます。
dromlakhani/MD2SKILL収集済み skill 858 件中 40 件を表示しています。
Selects the initial biochemical screening test for pheochromocytoma and paraganglioma based on test availability and clinical context. Triggers include patient presenting with palpitations, headaches, or hypertension; need to screen for PPGL in an…
原文の言語: 英語
Determines appropriate postoperative follow-up duration for PPGL based on hereditary status, catecholamine phenotype, tumor size, and location to guide surveillance intensity. Recommends lifelong follow-up for hereditary PPGL and at least 10 years for…
原文の言語: 英語
Assesses metastasis risk in PPGL using clinical factors such as age at diagnosis, tumor size, catecholamine secretion pattern, and tumor location. Indicated for newly diagnosed PPGL patients requiring risk stratification, evaluating metastatic potential, or…
原文の言語: 英語
Determines metastasis risk in PPGL using SDHB immunohistochemistry and genetic testing; integrates SDHB loss with tumor size, necrosis, vascular invasion, and S100 loss into COPPS score. Triggers include: 'PPGL tumor tissue available for…
原文の言語: 英語
Evaluates metastasis risk in pheochromocytoma and paraganglioma (PPGL) using histopathological scoring systems such as PASS and GAPP. Triggered when a pathology specimen is available from PPGL resection, when assessing tumor malignant potential on histology,…
原文の言語: 英語
Selects between CVD chemotherapy and radionuclide therapy as first-line systemic treatment for metastatic PPGL based on disease progression and imaging results. Triggers include PPGL with distant metastases requiring systemic therapy, assessing first-line…
原文の言語: 英語
Selects analgesic medications for PPGL pain management while avoiding agents that may provoke hypertensive crisis. Triggers include metastatic PPGL patient requiring pain management, assessing safe analgesic options in PPGL, and managing pain while preventing…
原文の言語: 英語
This skill assesses whether partial adrenalectomy is indicated for pheochromocytoma and paraganglioma (PPGL) to preserve adrenal function in patients with familial PPGL syndrome, imaging showing bilateral adrenal tumors or high-risk genetics, or young PPGL…
原文の言語: 英語
This skill applies the PASS score to evaluate malignant behavior in PPGL specimens as a reference tool for metastasis risk assessment. It is triggered by histopathological evaluation requiring PASS scoring, assessment of tumor malignant potential on…
原文の言語: 英語
This skill identifies when to investigate pediatric pheochromocytoma and paraganglioma (PPGL) in children presenting with hypertension accompanied by symptoms such as headache, sweating, palpitations, or reduced growth rate. It triggers investigation when…
原文の言語: 英語
Determines surgical approach for PPGL in children considering tumor size, suspected pathogenic gene variants, and hereditary tumor syndromes. Chooses between laparotomy and endoscopic surgery based on child's size and genetic risk; incorporates family history…
原文の言語: 英語
This skill initiates postoperative follow-up timing for pheochromocytoma and paraganglioma (PPGL) after surgical resection based on biochemical and imaging protocols. It is triggered by events such as the patient completing PPGL surgical resection, entering…
原文の言語: 英語
Selects safe imaging modalities for PPGL evaluation in pregnancy to minimize fetal radiation exposure, preferring ultrasound or MRI and reserving CT or 123I-MIBG scintigraphy for cases where diagnostic benefits outweigh radiation risks after informed consent.…
原文の言語: 英語
Manages PPGL medically in pregnancy by initiating selective alpha‑blockers at diagnosis and adding calcium antagonists (nifedipine or amlodipine) if blood pressure control is insufficient before delivery. Triggers include: 'Pregnant patient diagnosed with…
原文の言語: 英語
Determines optimal timing for surgical tumor removal in pregnant PPGL patients to balance maternal and fetal risks. Triggered by PPGL diagnosed in pregnant patient, assessing surgical feasibility during pregnancy, or planning intervention for PPGL in…
原文の言語: 英語
Selects preoperative alpha-blocker therapy and establishes initial dosing regimen for PPGL blood pressure control. Triggered by biochemically confirmed PPGL requiring surgery, patient needs preoperative blood pressure control, or preparing for adrenalectomy…
原文の言語: 英語
Implements preoperative salt loading and saline infusion to prevent orthostatic hypotension and hemodynamic instability during PPGL surgery. Initiates normal salt diet (9 g/day) on day 3 of alpha-blockers and administers 1-2 L saline infusion from evening…
原文の言語: 英語
Selects between 131I-MIBG and 177Lu-DOTATATE radionuclide therapy for PPGL based on imaging results. Triggers include PPGL patient requires radionuclide therapy, positive 123I-MIBG scintigraphy indicating MIBG-avid tumor, and positive somatostatin receptor…
原文の言語: 英語
This skill selects the surgical approach (laparoscopic/robot-assisted vs open adrenalectomy) for pheochromocytoma and paraganglioma (PPGL) based on tumor size and suspected organ invasion. It is triggered when imaging shows PPGL tumor size approaching 6 cm,…
原文の言語: 英語
Recommends against routine 25(OH)D testing in the general population aged 50 to 74 years. Triggered when a clinician considers ordering 25(OH)D for asymptomatic adults aged 50-74 without established indications such as hypocalcemia, malabsorption, or chronic…
原文の言語: 英語
The skill recommends against routine 25(OH)D testing in adults with dark complexion. Use when a clinician considers ordering a 25(OH)D test for a patient with dark complexion lacking established indications for vitamin D testing.
原文の言語: 英語
The Endocrine Society guideline recommends against routine 25(OH)D testing in asymptomatic adults without established indications for vitamin D assessment. Trigger when a clinician considers ordering a 25(OH)D level for a healthy adult with no symptoms of…
原文の言語: 英語
Recommends against routine screening for 25(OH)D levels in adults with obesity (BMI ≥30 kg/m²). Use when a clinician considers ordering a 25(OH)D test for an obese patient without established indications for vitamin D testing.
原文の言語: 英語
Recommends against routine 25(OH)D testing in adults aged 75 years and older. Use when a clinician considers ordering 25(OH)D for asymptomatic adults 75+ without established indications for vitamin D testing.
原文の言語: 英語
Recommends against routine 25(OH)D testing during pregnancy. Use when a clinician considers ordering 25(OH)D tests for pregnant patients lacking established indications such as hypocalcemia or malabsorption.
原文の言語: 英語
The skill advises against routine 25(OH)D testing in asymptomatic adults younger than 50 years who lack established indications for vitamin D assessment. It is triggered when a clinician considers ordering a 25(OH)D test for preventive screening in this age…
原文の言語: 英語
Recommends against routine vitamin D supplementation beyond the Dietary Reference Intake in adults aged 50 to 74 years. Use when a clinician considers vitamin D supplementation for adults aged 50-74 without established indications such as osteoporosis,…
原文の言語: 英語
Recommends against empiric vitamin D supplementation beyond the Dietary Reference Intake (DRI) in adults younger than 50 years. Use when a clinician considers vitamin D supplementation for non‑pregnant adults under 50 without established indications for…
原文の言語: 英語
Recommends daily, lower-dose vitamin D instead of nondaily, higher-dose vitamin D for adults aged 50 years and older who have an indication for vitamin D supplementation. Trigger phrases include 'vitamin D dosing strategy for patients over 50', 'daily versus…
原文の言語: 英語
Suggests empiric vitamin D supplementation to prevent nutritional rickets and potentially lower respiratory tract infection risk in children and adolescents aged 1 to 18 years. Use when a clinician asks about vitamin D supplementation for patients aged 1 to…
原文の言語: 英語
Suggests empiric vitamin D supplementation plus lifestyle modification to reduce diabetes progression risk in adults with high-risk prediabetes. Use when a clinician considers vitamin D for patients with prediabetes meeting 2 or more ADA glycemic criteria…
原文の言語: 英語
The skill suggests empiric vitamin D supplementation to lower mortality risk in adults aged 75 years and older. Use when a clinician inquires about vitamin D supplementation for patients aged 75 years or older to reduce mortality risk.
原文の言語: 英語
The guideline suggests empiric vitamin D supplementation during pregnancy to lower the risk of preeclampsia, intra-uterine mortality, preterm birth, small-for-gestational-age birth, and neonatal mortality. Consider this when a clinician inquires about vitamin…
原文の言語: 英語
Guides next-step management after a thyroid FNA result using the Bethesda System for Reporting Thyroid Cytopathology (categories I–VI), integrating clinical risk, sonographic pattern, and molecular testing options. Use when a clinician asks "what do I do with…
原文の言語: 英語
Reclassifies differentiated thyroid cancer (DTC) patients at 6–24 months after initial therapy using ATA response-to-therapy categories (Excellent / Biochemical Incomplete / Structural Incomplete / Indeterminate) to guide ongoing surveillance intensity, TSH…
原文の言語: 英語
Assigns ATA initial risk of recurrence (Low / Intermediate / High) to a patient with differentiated thyroid cancer (DTC) after surgery, using the ATA 2009 Modified Risk Stratification System. Use when a clinician asks "what is the ATA risk for this DTC…
原文の言語: 英語
Decides whether radioactive iodine (RAI) remnant ablation or adjuvant therapy is indicated after thyroidectomy for differentiated thyroid cancer, using ATA risk tier and specific pathologic features. Use when a clinician asks "does this DTC patient need RAI",…
原文の言語: 英語
Bedside protocol for recognising and managing adrenal crisis in an infant, child, or adolescent with classical congenital adrenal hyperplasia (CAH) — including triage clues, fluid resuscitation, IV hydrocortisone bolus and maintenance dosing (age-stratified),…
原文の言語: 英語
Calculate and prescribe oral hydrocortisone replacement in infants and young children with classical congenital adrenal hyperplasia (21-hydroxylase deficiency, SW or SV) — including dose (mg/m²/day), schedule, formulation, route, choice of agent, and what NOT…
原文の言語: 英語
Interpret a newborn screening (NBS) 17-hydroxyprogesterone (17-OHP) result for congenital adrenal hyperplasia (CAH) — including gestational-age and birth-weight adjusted cut-offs, when to repeat, when to run a second-tier LC-MS/MS multi-steroid profile, which…
原文の言語: 英語